Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis

NCT04652791 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT04652791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2020
Completion date
February 28, 2022
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis